Compound

A bit about us: docsend.com/view/i72yxz3

I think this is a slept on but very important post on frontier models and clinical trial outcome prediction, and I think the @PheironAI team is going to have a lot more to show soon.

Day 4, video #4. This hour-long, zero-shot autonomy video is a route I've done many times: from our London HQ to Heathrow 🇬🇧 Starting in London forced us to build autonomy that could scale. Compared to SF, London has 10x more cyclists, 15x more pedestrians and 20x more roadworks. This is what we've built at @wayve_ai. Check it out!

AI for scientific research continues to rapidly improve 🤖 Watch @TimothyDuignan demo how our chemistry agent used our simulation model, Orb-v3, to compute a crystal's phonon band structure, the microscopic blueprint that controls a material’s thermal properties. This is the kind of task an experimentalist would normally take to a computational chemist and wait days or weeks for the result. With our agent, it only took minutes; 272 messages and 137 tool calls later, it produced results matching the scientific literature. That's only possible because the agent can now check its own work, catch its mistakes, and verify its outputs at a level that produces trustworthy science. Watch the video below for more 👇

We want YOU to start a company and we want to pay you for it! We need to test our new platform that orchestrates agents to run an entire company. That's why we're launching The General Intelligence Fellowship. Build something cool with us, keep all of it, and get free money 🌻

We're announcing something pretty cool today - The General Intelligence Fellowship! We've been hard at work building out our new platform for starting and running a company with agents, and we want to bring on testers soon. You get 1000 dollars and a 100 dollars a day in credits to build out your idea on our platform. More details below - it's an exciting opportunity, check it out!

Introducing the General Intelligence Fellowship - get $1000 up front and $100/day in credits by starting a real company. More details below 🌻

Boston/Cambridge Idea Factory Event So often biotech confines innovation to "hammer-looking-for-a-nail" scenarios instead of thinking of the ultimate goal, first. @CompoundVC and @Ginkgo are joining forces to change the paradigm by creating an environment where people can discuss their tech visions with others, in person. ​This is the premise of an Idea Factory. Instead of name tags, we have idea tags so you'll lead with your ideas in your new conversations. ​Some past examples of ideas include: >​Self-evolving vaccines >Ozempic for social media dopamine >On-demand muscle modulation (fast/slow twitch) >Bi-directional memory encoding Ideas will be shared and voted at the the event so bring your best. ​We can't wait to explore your ideas soon! Event link under this post. Thanks @jasonkelly for supporting this idea. Excited!

We just published our second monthly newsletter highlighting our latest research, events, and must reads If you haven't already, subscribe at the link below!

Since publishing the human evidence playbook last year, so many people have reached out to us @CompoundVC when thinking about how to get into clinic as soon as possible. Truly a privilege to speak to them all and pumped for what this means for the field.

Last month, @CompoundVC launched a monthly newsletter that includes our latest research, theses, events, and must reads Sign up at the link below!

Full essay can be read here - tinyurl.com/aisafetyisouto…

(New essay) AI Safety Has 12 Months Left (if any time at all) Faster takeoff scenarios along with the events of the past week leave a narrow window to restructure AI safety as an enterprise premium instead of a consumer tax. If unable to execute this, the AI Safety movement is likely out of time.

NEW POD - heavily coded with @0xOmnia omnia is one of the cofounders of @kinetiq_xyz & @markets_xyz we discussed: > origin story > jeff's flirting with models pod > HL core team communication > product suite expansion > institutional demands > hiring & more links below

Presented how @ManifoldBio does rapid in vivo iteration at the aptly named "Rapid In Vivo Iteration" event in SF hosted by @shelbynewsad and @CompoundVC

Truly inspiring glimpse at faster, cheaper and even multiplexed in vivo evidence As asset generation commodifies & preclinical timelines trend to zero, this becomes even more of the key bottleneck to biomedical progress - Manifold & Gordian: massively multiplexed in vivo animal screening technologies - Sid Sijbrandij: going founder mode on his cancer and the companies he's creating to help others do the same - Presage: multiplexed Phase 0s to get human efficacy + MoA data on many drugs per cancer patient without IND or GMP - Pheiron: aggregates national scale multimodal biobank data to predict clinical outcomes - hVIVO: largest operator of human challenge trials for infectious diseases - Metabolis: running often decentralized trials to test nutraceuticals/food as medicine for rare or n-of-1 metabolic diseases - Medable: tech to run clinical ops more efficiently If you're exploring building in this space, it's never too early to talk with us! Thank you to @shelbynewsad for doing the hard work, to the speakers, audience, and SVB! @sytses @glebkuz @MartinBJensen @PresageBio @hVIVO_UK @SteinfeldtJakob @eperlste @medableinc

Wayve has secured $1.5B to deploy our embodied AI platform globally. Autonomy should work everywhere, in every condition, across every type of vehicle. We are building a driving intelligence that learns to drive in places it has never seen before.

citrini piece inspired by a smac / compound piece from 2023 few

slide from our last AGM this will only accelerate and increasingly execution will be the defining factor that determines who wins (hint: many of the names below will never again make a new ath)

Big appointments for Wayve: Welcome Girish Venkataramani (VP AI Platform) and Brandon Basso (VP AI Simulation, Data, Eval & Validation). Scaling embodied AI isn’t just about better models. It’s about platform, data and evaluation that earns trust.